The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer
- 26 January 2001
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 37 (1) , 61-67
- https://doi.org/10.1016/s1040-8428(00)00098-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Topotecan - A New Treatment Option in the Therapy of Brain Metastases of Lung CancerPublished by S. Karger AG ,1999
- Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trialEuropean Journal Of Cancer, 1997
- 1038: Topotecan (Hycamtin™) in small cell lung cancer (SCLC) after failure of first line therapy: Multicentre phase II studyEuropean Journal Of Cancer, 1997
- Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancerEuropean Journal Of Cancer, 1993
- A Randomized Trial of Surgery in the Treatment of Single Metastases to the BrainNew England Journal of Medicine, 1990
- Teniposide (VM26): An effective treatment for brain metastases of small cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1988
- Brain metastases from small cell lung cancer treated with combination chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1988
- Treatment of brain metastases of lung cancer with high doses of etoposide (VP16–213). Cooperative study from the groupe français pneumo-cancérologieEuropean Journal of Cancer and Clinical Oncology, 1988
- Intracranial metastases in small cell carcinoma of the lung prognostic aspectsCancer, 1983
- Comparison of symptomatic and prophylactic irradiation of brain metastases from oat cell carcinoma of the lungCancer, 1981